{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:32:46Z","timestamp":1774715566668,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"KAKENHI","doi-asserted-by":"crossref","award":["19K19372"],"award-info":[{"award-number":["19K19372"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s10120-025-01583-0","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T13:14:24Z","timestamp":1737465264000},"page":"544-549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Japanese family of hereditary diffuse gastric cancer with a germline pathogenic variant of CTNN1A detected via comprehensive genome profiling"],"prefix":"10.1007","volume":"28","author":[{"given":"Takeshi","family":"Kawakami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7050-2351","authenticated-orcid":false,"given":"Hiroyuki","family":"Matsubayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimi","family":"Kiyozumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rina","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiko","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuro","family":"Bando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakuni","family":"Serizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Sugino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"key":"1583_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","volume":"1","author":"S Hansford","year":"2015","unstructured":"Hansford S, Kaurah P, Li-Chang H, et al. Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond. JAMA Oncol. 2015;1:23\u201332.","journal-title":"JAMA Oncol"},{"key":"1583_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/jmedgenet-2015-103153","volume":"52","author":"PR Benusiglio","year":"2015","unstructured":"Benusiglio PR, Colas C, Rouleau E, et al. Hereditary diffuse gastric cancer syndrome: improved performances of the 2015 testing criteria for the identification of probands with a CDH1 germline mutation. J Med Genet. 2015;52:563\u20135.","journal-title":"J Med Genet"},{"issue":"897\u2013906","key":"1583_CR3","volume":"149","author":"RS van der Post","year":"2015","unstructured":"van der Post RS, Vogelaar IP, Manders P, et al. Accuracy of hereditary diffuse gastric cancer testing criteria and outcomes in patients with a germline mutation in CDH1. Gastroenterology. 2015;149(897\u2013906): e19.","journal-title":"Gastroenterology"},{"key":"1583_CR4","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/path.4152","volume":"229","author":"IJ Majewski","year":"2013","unstructured":"Majewski IJ, Kluijt I, Cats A, et al. An alpha-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer. J Pathol. 2013;229:621\u20139.","journal-title":"J Pathol"},{"key":"1583_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1136\/jmedgenet-2017-104962","volume":"55","author":"RDA Weren","year":"2018","unstructured":"Weren RDA, van der Post RS, Vogelaar IP, et al. Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility. J Med Genet. 2018;55:669\u201374.","journal-title":"J Med Genet"},{"key":"1583_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2021.104316","volume":"64","author":"S Lobo","year":"2021","unstructured":"Lobo S, Benusiglio PR, Coulet F, et al. Cancer predisposition and germline CTNNA1 variants. Eur J Med Genet. 2021;64: 104316.","journal-title":"Eur J Med Genet"},{"key":"1583_CR7","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1053\/j.gastro.2023.01.038","volume":"164","author":"L Decourtye-Espiard","year":"2023","unstructured":"Decourtye-Espiard L, Guilford P. Hereditary diffuse gastric cancer. Gastroenterology. 2023;164:719\u201335.","journal-title":"Gastroenterology"},{"key":"1583_CR8","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1016\/S1470-2045(20)30219-9","volume":"21","author":"VR Blair","year":"2020","unstructured":"Blair VR, McLeod M, Carneiro F, et al. Hereditary diffuse gastric cancer: updated clinical practice guidelines. Lancet Oncol. 2020;21:e386\u201397.","journal-title":"Lancet Oncol"},{"key":"1583_CR9","unstructured":"List of potentially actionable genes for secondary finding disclosure (Ver4.2). https:\/\/www.ncc.go.jp\/jp\/c_cat\/jitsumushya\/030\/Potentially_Actionable_SF_Gene_List_Ver4.2_20231003.pdf (2023)."},{"key":"1583_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"1583_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00439-020-02207-6","volume":"140","author":"Y Horiuchi","year":"2021","unstructured":"Horiuchi Y, Matsubayashi H, Kiyozumi Y, et al. Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients. Hum Genet. 2021;140:321\u201331.","journal-title":"Hum Genet"},{"key":"1583_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2021.101820","volume":"46","author":"L Taja-Chayeb","year":"2022","unstructured":"Taja-Chayeb L, Vidal-Millan S, Trejo-Becerril C, et al. Hereditary diffuse gastric cancer (HDGC). An overview. Clin Res Hepatol Gastroenterol. 2022;46: 101820.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"1583_CR13","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/sj.onc.1202348","volume":"18","author":"SJ Vermeulen","year":"1999","unstructured":"Vermeulen SJ, Nollet F, Teugels E, et al. The alphaE-catenin gene (CTNNA1) acts as an invasion-suppressor gene in human colon cancer cells. Oncogene. 1999;18:905\u201315.","journal-title":"Oncogene"},{"key":"1583_CR14","first-page":"5770","volume":"52","author":"Y Shimoyama","year":"1992","unstructured":"Shimoyama Y, Nagafuchi A, Fujita S, et al. Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness. Cancer Res. 1992;52:5770\u20134.","journal-title":"Cancer Res"},{"key":"1583_CR15","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/nature08768","volume":"463","author":"GR Bignell","year":"2010","unstructured":"Bignell GR, Greenman CD, Davies H, et al. Signatures of mutation and selection in the cancer genome. Nature. 2010;463:893\u20138.","journal-title":"Nature"},{"key":"1583_CR16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/gcc.22226","volume":"54","author":"B Lee","year":"2015","unstructured":"Lee B, Yoon K, Lee S, et al. Homozygous deletions at 3p22, 5p14, 6q15, and 9p21 result in aberrant expression of tumor suppressor genes in gastric cancer. Genes Chromosomes Cancer. 2015;54:142\u201355.","journal-title":"Genes Chromosomes Cancer"},{"key":"1583_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1349-7006.1994.tb02092.x","volume":"85","author":"A Ochiai","year":"1994","unstructured":"Ochiai A, Akimoto S, Shimoyama Y, et al. Frequent loss of alpha catenin expression in scirrhous carcinomas with scattered cell growth. Jpn J Cancer Res. 1994;85:266\u201373.","journal-title":"Jpn J Cancer Res"},{"key":"1583_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0002-9440(10)65575-7","volume":"153","author":"S Hirohashi","year":"1998","unstructured":"Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol. 1998;153:333\u20139.","journal-title":"Am J Pathol"},{"key":"1583_CR19","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s10120-013-0278-2","volume":"17","author":"S Sugimoto","year":"2014","unstructured":"Sugimoto S, Yamada H, Takahashi M, et al. Early-onset diffuse gastric cancer associated with a de novo large genomic deletion of CDH1 gene. Gastric Cancer. 2014;17:745\u20139.","journal-title":"Gastric Cancer"},{"key":"1583_CR20","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.3748\/wjg.v11.i22.3468","volume":"11","author":"YN Zhou","year":"2005","unstructured":"Zhou YN, Xu CP, Chen Y, et al. Alpha-catenin expression is decreased in patients with gastric carcinoma. World J Gastroenterol. 2005;11:3468\u201372.","journal-title":"World J Gastroenterol"},{"key":"1583_CR21","doi-asserted-by":"publisher","first-page":"8482","DOI":"10.1158\/0008-5472.CAN-09-1153","volume":"69","author":"Y Ye","year":"2009","unstructured":"Ye Y, McDevitt MA, Guo M, et al. Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies. Cancer Res. 2009;69:8482\u201390.","journal-title":"Cancer Res"},{"key":"1583_CR22","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1136\/jmg-2022-108740","volume":"59","author":"M Coudert","year":"2022","unstructured":"Coudert M, Drouet Y, Delhomelle H, et al. First estimates of diffuse gastric cancer risks for carriers of CTNNA1 germline pathogenic variants. J Med Genet. 2022;59:1189\u201395.","journal-title":"J Med Genet"},{"key":"1583_CR23","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41436-020-0753-1","volume":"22","author":"DF Clark","year":"2020","unstructured":"Clark DF, Michalski ST, Tondon R, et al. Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancer. Genet Med. 2020;22:840\u20136.","journal-title":"Genet Med"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-025-01583-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-025-01583-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-025-01583-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T01:01:47Z","timestamp":1768957307000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10120-025-01583-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1583"],"URL":"https:\/\/doi.org\/10.1007\/s10120-025-01583-0","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"assertion":[{"value":"4 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TK received honoraria for speaking symposia from Bristol-Myers Squibb Company and Ono Pharmaceutical Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent for the publication was obtained from the patient and his family members.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}